(ALBT) Avalon GloboCare - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock •

ALBT: Real Estate, Laboratory Services, Diagnostic Assets, Genetic Testing

Avalon GloboCare Corp. (NASDAQ:ALBT) operates as a commercial real estate owner and developer in the United States, focusing on property acquisition and management. The company also engages in the development of precision diagnostics and clinical laboratory services through strategic acquisitions, joint ventures, and distribution rights. Established in 2016, it is headquartered in Freehold, New Jersey. Web URL: https://www.avalon-globocare.com

Based on and , the 3-month forecast for ALBT suggests potential short-term bullish momentum due to its recent price crossing above the SMA20. However, the stock remains below SMA50 and SMA200, signaling longer-term bearish trends. The ATR of 0.81 indicates moderate volatility, with price swings expected to remain within a manageable range. highlights a high P/B ratio of 7.51, suggesting elevated valuations relative to book value. The P/S ratio of 3.17 reflects a premium pricing compared to sales, while the absence of P/E and forward P/E ratios points to ongoing profitability challenges. Overall, ALBT may experience sideways to upward movement in the near term but faces headwinds from its high valuation metrics and long-term technical resistance levels.

Additional Sources for ALBT Stock

ALBT Stock Overview

Market Cap in USD 12m
Sector Real Estate
Industry Real Estate Services
GiC Sub-Industry Real Estate Development
IPO / Inception 2016-12-06

ALBT Stock Ratings

Growth 5y -87.8%
Fundamental -7.36%
Dividend 0.0%
Rel. Strength Industry -22.1
Analysts -
Fair Price Momentum 2.68 USD
Fair Price DCF -

ALBT Dividends

No Dividends Paid

ALBT Growth Ratios

Growth Correlation 3m 53.6%
Growth Correlation 12m -39.6%
Growth Correlation 5y -98.2%
CAGR 5y -49.91%
CAGR/Max DD 5y -0.50
Sharpe Ratio 12m -0.68
Alpha -19.91
Beta 0.20
Volatility 263.83%
Current Volume 69k
Average Volume 20d 111.7k
What is the price of ALBT stocks?
As of March 16, 2025, the stock is trading at USD 4.89 with a total of 68,958 shares traded.
Over the past week, the price has changed by -32.37%, over one month by +32.52%, over three months by +26.68% and over the past year by -14.44%.
Is Avalon GloboCare a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Avalon GloboCare is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -7.36 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALBT as of March 2025 is 2.68. This means that ALBT is currently overvalued and has a potential downside of -45.19%.
Is ALBT a buy, sell or hold?
Avalon GloboCare has no consensus analysts rating.
What are the forecast for ALBT stock price target?
According to ValueRays Forecast Model, ALBT Avalon GloboCare will be worth about 2.9 in March 2026. The stock is currently trading at 4.89. This means that the stock has a potential downside of -40.7%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 2.9 -40.7%